Back
Enanta Pharmaceuticals Vs. Galectin Therapeutics Industry Stock Comparison
Sell
29
ENTA
Enanta Pharmaceuticals
Last Price:
13.05
Seasonality Move:
-0.7%
Buy
52
GALT
Galectin Therapeutics
Last Price:
3.15
Seasonality Move:
-7.91%
Sell
29
Enanta Pharmaceuticals (ENTA)
is a Sell
Is Enanta Pharmaceuticals a Buy, Sell or Hold?
- The current Enanta Pharmaceuticals [ENTA] share price is $13.06. The Score for ENTA is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- ENTA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Galectin Therapeutics (GALT)
is a Buy
Is Galectin Therapeutics a Buy, Sell or Hold?
- The current Galectin Therapeutics [GALT] share price is $3.14. The Score for GALT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- GALT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ENTA Stock Price Chart
What is Enanta Pharmaceuticals's stock price today?
-
The Enanta Pharmaceuticals share price today is $13.06
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ENTA is experiencing selling pressure, which indicates risk of future bearish movement.
GALT Stock Price Chart
What is Galectin Therapeutics's stock price today?
-
The Galectin Therapeutics share price today is $3.14
The current trend is relatively stagnant and GALT is experiencing buying pressure, which is a positive indicator for future bullish movement.
ENTA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.42 | Sell |
| Relative Strength Index (14 RSI): | 43.95 | Sell |
| Chaikin Money Flow: | -64297 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.57 - 14.71) | Sell |
| Bollinger Bands (100): | (11.6 - 15.3) | Sell |
GALT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 48.54 | Sell |
| Chaikin Money Flow: | 39605 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.1 - 3.6) | Sell |
| Bollinger Bands (100): | (1.62 - 3.14) | Buy |
ENTA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13 | Buy |
| 20-day SMA: | 13.29 | Sell |
| 50-day SMA: | 14.57 | Sell |
| 200-day SMA: | 12.47 | Buy |
| 8-day EMA: | 13.2 | Sell |
| 20-day EMA: | 13.57 | Sell |
| 50-day EMA: | 13.91 | Sell |
| 200-day EMA: | 16.07 | Sell |
GALT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.12 | Buy |
| 20-day SMA: | 3.29 | Sell |
| 50-day SMA: | 2.98 | Buy |
| 200-day SMA: | 2.11 | Buy |
| 8-day EMA: | 3.13 | Buy |
| 20-day EMA: | 3.21 | Sell |
| 50-day EMA: | 2.98 | Buy |
| 200-day EMA: | 2.28 | Buy |
Enanta Pharmaceuticals Earnings Growth & ENTA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.30 per share, an increase this year of $1.36 per share, and an increase next year of $0.46 per share.
Galectin Therapeutics Earnings Growth & GALT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Enanta Pharmaceuticals Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Galectin Therapeutics Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||